Status:
COMPLETED
Impact of Acquired FXIII Deficiency on Morbidity and Mortality
Lead Sponsor:
Patricia Duque González
Conditions:
Acquired Factor XIII Deficiency Disease
Eligibility:
All Genders
Brief Summary
Observational prospective study aiming to assess acquired FXIII deficiency implications in morbidity and mortality
Detailed Description
All patients admitted to a large tertiary hospital with FXIII levels below 70% during their hospital stay are assessed. Data regarding patient background, blood transfusion, morbidity and mortality is...
Eligibility Criteria
Inclusion
- FXIII levels \< 70%
Exclusion
- None
Key Trial Info
Start Date :
September 10 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 18 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04416594
Start Date
September 10 2019
End Date
May 18 2020
Last Update
June 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gregorio Marañon Hospital
Madrid, Spain, 28007